Mary Kay Ash Foundation and UT Southwestern celebrate five years of successful collaboration in advancing cancer research

NewsGuard 100/100 Score

The Mary Kay Ash Foundation, a decades-long leader and advocate for finding cures for cancers affecting women, and UT Southwestern Medical Center, one of the nation’s premier academic medical centers, in Dallas, Texas, are celebrating five years of collaborative success on the International Postdoctoral Scholars in Cancer Research Fellowship program. Hosted at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, the fellowship is a two-year postdoctoral program sponsored by the Mary Kay Ash Foundation.

Mary Kay Ash Foundation and UT Southwestern celebrate five years of successful collaboration in advancing cancer research
International Postdoctoral Scholars in Cancer Research, Class of 2023. Back Row: Dongqi Xie, Ph.D. (left), Principal Investigator Jerry Shay, Ph.D. (middle), Pedro Nogueira, Ph.D. (right); Front Row: Debora Andrade Silva, Ph.D. (left), Hong-Yi Liu, Ph.D. (middle), and Maria Del Chica Parrado, Ph.D. (right). Image Credit: Mary Kay Inc.

Established in 2019, the program set out to recruit exemplary international researchers in their respective fields, provide them with invaluable experience, mentorship, and a return grant to continue their pursuits in their home country - bringing their knowledge and experience gained with them.

To date, the program has successfully recruited 13 highly accomplished postdoctoral researchers from Brazil, China, Germany, Mexico, Singapore, Spain and Portugal - seven of which have successfully completed the program; six continue to actively pursue their respective research projects in Dallas; and all have made impactful contributions to notable research publications.

For more than two decades, the Mary Kay Ash Foundation and UT Southwestern Medical Center have partnered in a continued commitment to find cures for cancers affecting women. Our partnership continues to bring pivotal innovations to the cancer research frontlines by removing barriers and encouraging information sharing across borders and the world. These findings will be shared on a global level and impact women in every corner of the world.”

Michael Lunceford, President, Mary Kay Ash Foundation Board of Directors

Under the expert guidance of Dr. Jerry Shay, Professor of Cell Biology and The Southland Financial Corporation Distinguished Chair in Geriatrics at UT Southwestern Medical Center, the program has consistently attracted and recruited exceptional candidates, ensuring the participation of highly qualified individuals from diverse geographic areas. In the most recent recruitment efforts, two outstanding scholars were recruited to the program: Debora Andrade Silva, Ph.D., from the University of Sao Paulo in Brazil, and Quan Wang, Ph.D., from Shanghai Jiao Tong University in China.

“We appreciate Mary Kay Ash Foundation’s continued investment in UT Southwestern Medical Center and the future of cancer research. With the foundation’s support, we can attract top international candidates, bring them to our state-of-the-art facilities to work with accomplished mentors, and make great strides in research advancements,” said Dr. Jerry Shay. “The global postdoctoral grant allows diverse cancer research talent the opportunity to conduct cutting-edge cancer research at both UT Southwestern Simmons Cancer Center and back in their home country.”

The Mary Kay Ash Foundation is proud to continue its long legacy of making the world a safer, healthier place for women and their families.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases